OtherCARDIOVASCULAR PHARMACOLOGY
In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461
Margaret Van Heek, Constance F. France, Douglas S. Compton, Robbie L. Mcleod, Nathan P. Yumibe, Kevin B. Alton, Edmund J. Sybertz and Harry R. Davis Jr.
Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 157-163;
Margaret Van Heek
Constance F. France
Douglas S. Compton
Robbie L. Mcleod
Nathan P. Yumibe
Kevin B. Alton
Edmund J. Sybertz
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 283, Issue 1
1 Oct 1997
OtherCARDIOVASCULAR PHARMACOLOGY
In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461
Margaret Van Heek, Constance F. France, Douglas S. Compton, Robbie L. Mcleod, Nathan P. Yumibe, Kevin B. Alton, Edmund J. Sybertz and Harry R. Davis
Journal of Pharmacology and Experimental Therapeutics October 1, 1997, 283 (1) 157-163;
OtherCARDIOVASCULAR PHARMACOLOGY
In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461
Margaret Van Heek, Constance F. France, Douglas S. Compton, Robbie L. Mcleod, Nathan P. Yumibe, Kevin B. Alton, Edmund J. Sybertz and Harry R. Davis
Journal of Pharmacology and Experimental Therapeutics October 1, 1997, 283 (1) 157-163;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement